Cargando…
Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
PURPOSE: Adaptive stereotactic body radiation therapy (SBRT) for prostate cancer (PC) by the 1.5 T MR-linac currently requires online planning by an expert user. A fully automated and user-independent solution to adaptive planning (mCycle) of PC-SBRT was compared with user's plans for the 1.5 T...
Autores principales: | Naccarato, Stefania, Rigo, Michele, Pellegrini, Roberto, Voet, Peter, Akhiat, Hafid, Gurrera, Davide, De Simone, Antonio, Sicignano, Gianluisa, Mazzola, Rosario, Figlia, Vanessa, Ricchetti, Francesco, Nicosia, Luca, Giaj-Levra, Niccolò, Cuccia, Francesco, Stavreva, Nadejda, Pressyanov, Dobromir S., Stavrev, Pavel, Alongi, Filippo, Ruggieri, Ruggero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850203/ https://www.ncbi.nlm.nih.gov/pubmed/35198836 http://dx.doi.org/10.1016/j.adro.2021.100865 |
Ejemplares similares
-
1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes
por: Cuccia, Francesco, et al.
Publicado: (2022) -
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
por: Alongi, Filippo, et al.
Publicado: (2020) -
Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system
por: Giaj-Levra, Niccolò, et al.
Publicado: (2021) -
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients
por: Alongi, Filippo, et al.
Publicado: (2022) -
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy
por: Cuccia, Francesco, et al.
Publicado: (2020)